Warren Buffett's Berkshire Hathaway Doubled Down on Constellation Brands Stock. Time to Buy?

Berkshire Hathaway increased its stake in Constellation Brands (STZ) by 116% in Q1, making it the portfolio's fastest-growing position, likely capitalizing on a stock sell-off following disappointing Q3 fiscal 2025 results. Constellation's low forward P/E ratio of 15, a dividend yield above the S&P 500 average, and a history of payout hikes make it an attractive income stock, though concerns remain about shifting consumer preferences, potential tariffs, and revised net sales growth forecasts, which could impact future performance.

Analysis

Berkshire Hathaway significantly increased its Constellation Brands (STZ) stake by 116% in Q1, making it the portfolio's fastest-growing position, with total holdings now exceeding 12 million shares. This strategic accumulation, initiated in Q4 2024, likely capitalized on a substantial stock price decline after Constellation reported disappointing Q3 fiscal 2025 results (ended Nov. 30, 2024), which included misses on net sales and earnings, and a $2.25 billion goodwill impairment, causing an immediate stock drop of over 17%. Despite the stock having recovered approximately 20% from its 52-week low, its current valuation presents a mixed picture: a high trailing P/E ratio of 47 reflecting the impairment, contrasted with a more favorable forward P/E ratio of 15, which likely underpins Berkshire's investment thesis. Constellation's appeal is further bolstered by a robust dividend profile, offering an annual payout of $4.08 per share, translating to a 2.1% yield—notably above the S&P 500 average of 1.3%. This dividend is supported by strong free cash flow generation, which was just over $1.9 billion in fiscal 2025 (ended Feb. 28), against dividend costs of $732 million, and a track record of ten consecutive years of payout increases. However, significant headwinds persist, including potentially declining long-term alcohol demand, particularly among Gen Z, softening overall consumer spending, and the vulnerability of its key foreign-sourced brands, such as Modelo, to tariffs. These concerns have led Constellation to revise its net sales growth forecast downward to -2% to 1% for fiscal 2026, and to a 2% to 4% range for its medium-term outlook (fiscal 2027-2028), a reduction from the previous 6% to 8% projection.

Key Decisions for Investors

• Investors might consider Constellation Brands, given its forward P/E of 15 and a dividend yield above 2%, supported by Berkshire Hathaway's increased stake and the article's assessment that the stock appears to be a buy, particularly if the recent sell-off is viewed as overdone.
• It is crucial to diligently monitor shifts in consumer behavior, especially alcohol consumption trends among Gen Z and broader patterns in discretionary spending, as these are key variables impacting Constellation's revised and lowered sales growth projections.
• Careful assessment of potential tariff impacts on major imported brands like Modelo, and the company's performance against its adjusted net sales growth targets of -2% to 1% for fiscal 2026 and 2% to 4% for the medium term, is essential before initiating or adjusting positions in the stock.